(Q38460277)

3 September 2017

title

Calcitonin is a prostate epithelium-derived growth stimulatory peptide (English)

1 reference

3 September 2017

1

1 reference

3 September 2017

Y Ren

2

1 reference

3 September 2017

Y Qing Wang

3

1 reference

3 September 2017

W Bordelon

4

1 reference

3 September 2017

E Thompson

5

1 reference

3 September 2017

R Davis

6

1 reference

3 September 2017

W Rayford

7

1 reference

3 September 2017

G Shah

8

1 reference

3 September 2017

publication date

1 July 2001

1 reference

Molecular and Cellular Endocrinology

3 September 2017

published in

1 reference

3 September 2017

volume

181

1 reference

3 September 2017

issue

1-2

1 reference

3 September 2017

page(s)

69-79

1 reference

Large Shionogi tumors lose their responsiveness to flutamide treatment

3 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900530-5

7 January 2021

Role of stimulatory guanine nucleotide binding protein (GSalpha) in proliferation of PC-3M prostate cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900530-5

7 January 2021

Relationship of neuroendocrine cells of prostate and serotonin to benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900530-5

7 January 2021

Neuroendocrine differentiation in prostatic adenocarcinoma and its relationship to tumor progression

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900530-5

7 January 2021

Androgen-independent growth is induced by neuropeptides in human prostate cancer cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900530-5

7 January 2021

Elevated Plasma Chromogranin-A Concentrations in Prostatic Carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900530-5

7 January 2021

Cell-cell interaction in prostate gene regulation and cytodifferentiation

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900530-5

7 January 2021

What is 'progression' in prostate cancer?

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900530-5

7 January 2021

The management of hormone refractory prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900530-5

7 January 2021

Stimulation of human prostatic carcinoma tumor growth in athymic mice and control of migration in culture by extracellular matrix

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900530-5

7 January 2021

Neurotensin is an autocrine trophic factor stimulated by androgen withdrawal in human prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900530-5

7 January 2021

Presence of calcitonin-like peptide in rat milk: possible physiological role in regulation of neonatal prolactin secretion

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900530-5

7 January 2021

Presence of calcitonin-like immunoreactivity (iCT) in human prostate gland: evidence for iCT secretion by cultured prostate cells

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900530-5

7 January 2021

Calcitonin stimulates growth of human prostate cancer cells through receptor-mediated increase in cyclic adenosine 3',5'-monophosphates and cytoplasmic Ca2+ transients

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900530-5

7 January 2021

Calcitonin receptor mRNA expression in the human prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900530-5

7 January 2021

10.1016/S0303-7207(01)00530-5

Identifiers

DOI

1 reference

3 September 2017

1 reference